BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cojocaru FD, Botezat D, Gardikiotis I, Uritu CM, Dodi G, Trandafir L, Rezus C, Rezus E, Tamba BI, Mihai CT. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 2020;12:E171. [PMID: 32085535 DOI: 10.3390/pharmaceutics12020171] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 31.5] [Reference Citation Analysis]
Number Citing Articles
1 Carvalho GC, Araujo VHS, Fonseca-Santos B, de Araújo JTC, de Souza MPC, Duarte JL, Chorilli M. Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections. Int J Pharm 2021;602:120635. [PMID: 33895295 DOI: 10.1016/j.ijpharm.2021.120635] [Reference Citation Analysis]
2 García-Fernández A, Sancenón F, Martínez-Máñez R. Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev 2021;177:113953. [PMID: 34474094 DOI: 10.1016/j.addr.2021.113953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
3 Kumawat M, Umapathi A, Lichtfouse E, Daima HK. Nanozymes to fight the COVID-19 and future pandemics. Environ Chem Lett 2021;:1-7. [PMID: 34031634 DOI: 10.1007/s10311-021-01252-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li W, Thian ES, Wang M, Wang Z, Ren L. Surface Design for Antibacterial Materials: From Fundamentals to Advanced Strategies. Adv Sci (Weinh) 2021;8:e2100368. [PMID: 34351704 DOI: 10.1002/advs.202100368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
5 Ertas YN, Mahmoodi M, Shahabipour F, Jahed V, Diltemiz SE, Tutar R, Ashammakhi N. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). Emergent Mater 2021;:1-21. [PMID: 33748672 DOI: 10.1007/s42247-021-00165-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Upadhyay SK, Dan S, Girdhar M, Rastogi K. Recent Advancement in SARS-CoV-2 Diagnosis, Treatment, and Vaccine Formulation: a New Paradigm of Nanotechnology in Strategic Combating of COVID-19 Pandemic. Curr Pharmacol Rep 2021;:1-14. [PMID: 33552875 DOI: 10.1007/s40495-021-00250-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Mukubwa GK, Safari JB, Walker RB, Krause RWM. Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz. Pharmaceutics 2022;14:1318. [DOI: 10.3390/pharmaceutics14071318] [Reference Citation Analysis]
8 Ninfali P, Antonelli A, Magnani M, Scarpa ES. Antiviral Properties of Flavonoids and Delivery Strategies. Nutrients 2020;12:E2534. [PMID: 32825564 DOI: 10.3390/nu12092534] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
9 Vazquez-munoz R, Lopez-ribot JL. Nanotechnology as an Alternative to Reduce the Spread of COVID-19. Challenges 2020;11:15. [DOI: 10.3390/challe11020015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
10 Huda S, Alam MA, Sharma PK. Smart nanocarriers-based drug delivery for cancer therapy: An innovative and developing strategy. Journal of Drug Delivery Science and Technology 2020;60:102018. [DOI: 10.1016/j.jddst.2020.102018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
11 Hu X, Jia C, Wu J, Zhang J, Jiang Z, Ma K. Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19. Front Cell Infect Microbiol 2022;12:916012. [DOI: 10.3389/fcimb.2022.916012] [Reference Citation Analysis]
12 Rai PK, Usmani Z, Thakur VK, Gupta VK, Mishra YK. Tackling COVID-19 pandemic through nanocoatings: Confront and exactitude. Current Research in Green and Sustainable Chemistry 2020;3:100011. [DOI: 10.1016/j.crgsc.2020.100011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
13 Formiga FR, Leblanc R, de Souza Rebouças J, Farias LP, de Oliveira RN, Pena L. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19. J Control Release 2021;329:758-61. [PMID: 33038449 DOI: 10.1016/j.jconrel.2020.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
14 Nasrollahzadeh M, Sajjadi M, Soufi GJ, Iravani S, Varma RS. Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses. Nanomaterials (Basel) 2020;10:E1072. [PMID: 32486364 DOI: 10.3390/nano10061072] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 22.0] [Reference Citation Analysis]
15 Mukherjee S, Mazumder P, Joshi M, Joshi C, Dalvi SV, Kumar M. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review. Environ Res 2020;191:110119. [PMID: 32846177 DOI: 10.1016/j.envres.2020.110119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
16 Khoshnevisan K, Maleki H, Baharifar H. Nanobiocide Based-Silver Nanomaterials Upon Coronaviruses: Approaches for Preventing Viral Infections. Nanoscale Res Lett 2021;16:100. [PMID: 34095961 DOI: 10.1186/s11671-021-03558-3] [Reference Citation Analysis]
17 Amirova A, Rodchenko S, Kurlykin M, Tenkovtsev A, Krasnou I, Krumme A, Filippov A. Synthesis and Investigation of Thermo-Induced Gelation of Partially Cross-Linked Poly-2-isopropyl-2-oxazoline in Aqueous Media. Polymers (Basel) 2020;12:E698. [PMID: 32245164 DOI: 10.3390/polym12030698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sultana A, Zare M, Thomas V, Kumar TS, Ramakrishna S. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects. Medicine in Drug Discovery 2022;15:100134. [DOI: 10.1016/j.medidd.2022.100134] [Reference Citation Analysis]
19 Xu X, Li T, Jin K. Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy. Pharmaceutics 2022;14:1109. [PMID: 35631695 DOI: 10.3390/pharmaceutics14051109] [Reference Citation Analysis]
20 Weiss C, Carriere M, Fusco L, Capua I, Regla-Nava JA, Pasquali M, Scott JA, Vitale F, Unal MA, Mattevi C, Bedognetti D, Merkoçi A, Tasciotti E, Yilmazer A, Gogotsi Y, Stellacci F, Delogu LG. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. ACS Nano 2020;14:6383-406. [PMID: 32519842 DOI: 10.1021/acsnano.0c03697] [Cited by in Crossref: 277] [Cited by in F6Publishing: 226] [Article Influence: 138.5] [Reference Citation Analysis]
21 Zare M, Sillanpää M, Ramakrishna S. Essential role of quantum science and nanoscience in antiviral strategies for COVID-19. Mater Adv 2021;2:2188-99. [DOI: 10.1039/d1ma00060h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
22 Shah S, Chougule MB, Kotha AK, Kashikar R, Godugu C, Raghuvanshi RS, Singh SB, Srivastava S. Nanomedicine based approaches for combating viral infections. J Control Release 2021;338:80-104. [PMID: 34375690 DOI: 10.1016/j.jconrel.2021.08.011] [Reference Citation Analysis]
23 Sadeghian I, Heidari R, Sadeghian S, Raee MJ, Negahdaripour M. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. Eur J Pharm Sci 2021;169:106094. [PMID: 34896590 DOI: 10.1016/j.ejps.2021.106094] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Aydoğmuş Z, Asfoor A. Electroanalytical Methods for Determination of Antiviral Drugs in Pharmaceutical Formulation and Biological Fluids: A Review. Chinese Journal of Analytical Chemistry 2022. [DOI: 10.1016/j.cjac.2022.100063] [Reference Citation Analysis]
25 de M Ribeiro LN, Fonseca BB. The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic. Future Microbiol 2020;15:1571-82. [PMID: 33215525 DOI: 10.2217/fmb-2020-0118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
26 Franklyne JS, Gopinath PM, Mukherjee A, Chandrasekaran N. Nanoemulsions: The rising star of antiviral therapeutics and nanodelivery system-current status and prospects. Curr Opin Colloid Interface Sci 2021;54:101458. [PMID: 33814954 DOI: 10.1016/j.cocis.2021.101458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
27 Kim E, Lim EK, Park G, Park C, Lim JW, Lee H, Na W, Yeom M, Kim J, Song D, Haam S. Advanced Nanomaterials for Preparedness Against (Re-)Emerging Viral Diseases. Adv Mater 2021;33:e2005927. [PMID: 33586180 DOI: 10.1002/adma.202005927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
28 Jain A, Prajapati SK, Tripathi M, Raichur AM, Kanwar JR. Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights. Expert Rev Clin Pharmacol 2021;14:715-34. [PMID: 33769888 DOI: 10.1080/17512433.2021.1909473] [Reference Citation Analysis]
29 Rana MM. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. J Biomater Sci Polym Ed 2021;32:1219-49. [PMID: 33787467 DOI: 10.1080/09205063.2021.1909412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Ibrahim Fouad G. A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19). Bull Natl Res Cent 2021;45:36. [PMID: 33564223 DOI: 10.1186/s42269-021-00487-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Tavakol S, Zahmatkeshan M, Mohammadinejad R, Mehrzadi S, Joghataei MT, Alavijeh MS, Seifalian A. The role of nanotechnology in current COVID-19 outbreak. Heliyon 2021;7:e06841. [PMID: 33880422 DOI: 10.1016/j.heliyon.2021.e06841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Gokce C, Gurcan C, Besbinar O, Unal MA, Yilmazer A. Emerging 2D materials for antimicrobial applications in the pre- and post-pandemic era. Nanoscale 2021. [PMID: 34935015 DOI: 10.1039/d1nr06476b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Delshadi R, Bahrami A, McClements DJ, Moore MD, Williams L. Development of nanoparticle-delivery systems for antiviral agents: A review. J Control Release 2021;331:30-44. [PMID: 33450319 DOI: 10.1016/j.jconrel.2021.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
34 Lawal SK, Olojede SO, Dare A, Faborode OS, Naidu ECS, Rennie CO, Azu OO. Silver Nanoparticles Conjugate Attenuates Highly Active Antiretroviral Therapy-Induced Hippocampal Nissl Substance and Cognitive Deficits in Diabetic Rats. J Diabetes Res 2021;2021:2118538. [PMID: 34840987 DOI: 10.1155/2021/2118538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Muhammad W, Zhai Z, Gao C. Antiviral Activity of Nanomaterials against Coronaviruses. Macromol Biosci 2020;20:e2000196. [PMID: 32783352 DOI: 10.1002/mabi.202000196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. ACS Biomater Sci Eng 2021;7:2150-76. [PMID: 33979143 DOI: 10.1021/acsbiomaterials.1c00318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Maus A, Strait L, Zhu D. Nanoparticles as delivery vehicles for antiviral therapeutic drugs. Engineered Regeneration 2021;2:31-46. [DOI: 10.1016/j.engreg.2021.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
38 Tortella GR, Pieretti JC, Rubilar O, Fernández-Baldo M, Benavides-Mendoza A, Diez MC, Seabra AB. Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives. Crit Rev Biotechnol 2021;:1-19. [PMID: 34233551 DOI: 10.1080/07388551.2021.1939260] [Reference Citation Analysis]
39 Chan Y, Ng SW, Mehta M, Anand K, Kumar Singh S, Gupta G, Chellappan DK, Dua K. Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis. Med Hypotheses 2020;144:110298. [PMID: 33254489 DOI: 10.1016/j.mehy.2020.110298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
40 Pandey A, Nikam AN, Mutalik SP, Fernandes G, Shreya AB, Padya BS, Raychaudhuri R, Kulkarni S, Prassl R, Subramanian S, Korde A, Mutalik S. Architectured Therapeutic and Diagnostic Nanoplatforms for Combating SARS-CoV-2: Role of Inorganic, Organic, and Radioactive Materials. ACS Biomater Sci Eng 2021;7:31-54. [PMID: 33371667 DOI: 10.1021/acsbiomaterials.0c01243] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Gurunathan S, Qasim M, Choi Y, Do JT, Park C, Hong K, Kim JH, Song H. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses? Nanomaterials (Basel) 2020;10:E1645. [PMID: 32825737 DOI: 10.3390/nano10091645] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 19.5] [Reference Citation Analysis]
42 Valentino A, Di Cristo F, Bosetti M, Amaghnouje A, Bousta D, Conte R, Calarco A. Bioactivity and Delivery Strategies of Phytochemical Compounds in Bone Tissue Regeneration. Applied Sciences 2021;11:5122. [DOI: 10.3390/app11115122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
43 F Nahhas A, F Nahhas A, J Webster T. Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics. Nanomedicine (Lond) 2021;16:1237-54. [PMID: 33988037 DOI: 10.2217/nnm-2020-0447] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Bonam SR, Kotla NG, Bohara RA, Rochev Y, Webster TJ, Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021;36:101051. [PMID: 33519949 DOI: 10.1016/j.nantod.2020.101051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
45 Sheikh A, Kesharwani P. An insight into aptamer engineered dendrimer for cancer therapy. European Polymer Journal 2021;159:110746. [DOI: 10.1016/j.eurpolymj.2021.110746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
46 Alimardani V, Abolmaali SS, Tamaddon AM, Singh BP. Recent Advances on Nanotechnology-Based Strategies for Prevention, Diagnosis, and Treatment of Coronavirus Infections. Journal of Nanomaterials 2021;2021:1-20. [DOI: 10.1155/2021/9495126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
47 Donalisio M, Argenziano M, Rittà M, Bastiancich C, Civra A, Lembo D, Cavalli R. Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections. International Journal of Pharmaceutics 2020;587:119676. [DOI: 10.1016/j.ijpharm.2020.119676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
48 Chintagunta AD, M SK, Nalluru S, N S SK. Nanotechnology: an emerging approach to combat COVID-19. Emergent Mater 2021;:1-12. [PMID: 33615141 DOI: 10.1007/s42247-021-00178-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
49 Ranjbar S, Fatahi Y, Atyabi F. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19? J Drug Deliv Sci Technol 2021;:102899. [PMID: 34630635 DOI: 10.1016/j.jddst.2021.102899] [Reference Citation Analysis]
50 Wieczorek K, Szutkowska B, Kierzek E. Anti-Influenza Strategies Based on Nanoparticle Applications. Pathogens 2020;9:E1020. [PMID: 33287259 DOI: 10.3390/pathogens9121020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Unal MA, Bayrakdar F, Fusco L, Besbinar O, Shuck CE, Yalcin S, Erken MT, Ozkul A, Gurcan C, Panatli O, Summak GY, Gokce C, Orecchioni M, Gazzi A, Vitale F, Somers J, Demir E, Yildiz SS, Nazir H, Grivel JC, Bedognetti D, Crisanti A, Akcali KC, Gogotsi Y, Delogu LG, Yilmazer A. 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2. Nano Today 2021;38:101136. [PMID: 33753982 DOI: 10.1016/j.nantod.2021.101136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
52 Mba IE, Sharndama HC, Osondu-Chuka GO, Okeke OP. Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update. Infect Dis (Lond) 2021;53:559-80. [PMID: 33905282 DOI: 10.1080/23744235.2021.1916071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Zhang G, Yue K, Wang A, Zhong W, Yang P, Wang L, Ye X, Sun X. Self-assembly and disassembly mechanisms of biomimetic peptides: Molecular dynamics simulation and experimental measurement. Int J Biol Macromol 2022;209:785-93. [PMID: 35429517 DOI: 10.1016/j.ijbiomac.2022.04.069] [Reference Citation Analysis]
54 Safarzadeh M, Sadeghi S, Azizi M, Rastegari-Pouyani M, Pouriran R, Haji Molla Hoseini M. Chitin and chitosan as tools to combat COVID-19: A triple approach. Int J Biol Macromol 2021;183:235-44. [PMID: 33930442 DOI: 10.1016/j.ijbiomac.2021.04.157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Sun Z, Ostrikov K(. Future antiviral surfaces: Lessons from COVID-19 pandemic. Sustainable Materials and Technologies 2020;25:e00203. [DOI: 10.1016/j.susmat.2020.e00203] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 10.5] [Reference Citation Analysis]
56 Kumari S, Chatterjee K. Biomaterials-based formulations and surfaces to combat viral infectious diseases. APL Bioeng 2021;5:011503. [PMID: 33598595 DOI: 10.1063/5.0029486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Acharya D, Satapathy S, Yadav KK, Somu P, Mishra G. Systemic Evaluation of Mechanism of Cytotoxicity in Human Colon Cancer HCT-116 Cells of Silver Nanoparticles Synthesized Using Marine Algae Ulva lactuca Extract. J Inorg Organomet Polym. [DOI: 10.1007/s10904-021-02133-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Hasanzadeh A, Alamdaran M, Ahmadi S, Nourizadeh H, Bagherzadeh MA, Mofazzal Jahromi MA, Simon P, Karimi M, Hamblin MR. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. J Control Release 2021;336:354-74. [PMID: 34175366 DOI: 10.1016/j.jconrel.2021.06.036] [Reference Citation Analysis]
59 Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang C, Zhang Z. Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharm Sin B 2021;11:3060-91. [PMID: 33977080 DOI: 10.1016/j.apsb.2021.04.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
60 Zare M, Thomas V, Ramakrishna S. Nanoscience and quantum science-led biocidal and antiviral strategies. J Mater Chem B 2021. [PMID: 34378553 DOI: 10.1039/d0tb02639e] [Reference Citation Analysis]
61 Mauriello E, Ferrari G, Donsì F. Effect of formulation on properties, stability, carvacrol release and antimicrobial activity of carvacrol emulsions. Colloids Surf B Biointerfaces 2021;197:111424. [PMID: 33099148 DOI: 10.1016/j.colsurfb.2020.111424] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
62 Chis AA, Dobrea C, Morgovan C, Arseniu AM, Rus LL, Butuca A, Juncan AM, Totan M, Vonica-Tincu AL, Cormos G, Muntean AC, Muresan ML, Gligor FG, Frum A. Applications and Limitations of Dendrimers in Biomedicine. Molecules 2020;25:E3982. [PMID: 32882920 DOI: 10.3390/molecules25173982] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
63 Kumar M, Jain CP. Possible Benefits of Reformulating Antiviral Drugs with Nanoemulsion System in the Treatment of Novel Coronavirus Infection. COVID 2021;2:411-4. [DOI: 10.2174/2666796701999201014160116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]